Oral semaglutide side effects usually happen during the dose-escalation period , which lasts about 90 days for the tablet
However, Becton, Dickinson is slowly turning things around, and its exposure to the GLP-1 market may help
Theyre designed to be used over time, alongside nutrition, behavior change, and ongoing medical supervision
In clinical trials, semaglutide has demonstrated robust reductions in hemoglobin A1c (HbA1c), with mean decreases ranging from 1.0% to 1.8% depending on the dose and patient population
1, Blue Cross has required prior authorization for the GLP-1 diabetes drugs including Ozempic
Now, if I were to ask you a question, what the percentage of people that are dealing with being overweight is and what percentage of people are obese, that will be the next slide